Who is sponsoring NCT05135182?

NCT05135182 is sponsored by Shandong University.

What condition does NCT05135182 study?

NCT05135182 studies Helicobacter Pylori Infection.

What drugs are being tested in NCT05135182?

Interventions: Furazolidone, Metronidazole.

What is the status of NCT05135182?

NCT05135182 is currently UNKNOWN.

Last reviewed 2021-11-28 · How we verify

Helicobacter Pylori Rescue Treatment Containing Tetracycline in Patients Allergic to Penicillin:a Prospective Randomized Controlled Study

NCT05135182 Phase 4 UNKNOWN

The purpose of this study is to assess and compare the effectiveness of furazolidone-tetracycline-containing and metronidazole-tetracycline-containing quadruple regimens for the rescue treatment of Helicobacter pylori infection inpatients allergic to penicillin.

Details

Lead sponsor	Shandong University
Phase	Phase 4
Status	UNKNOWN
Enrolment	170
Start date	2021-11-28
Completion	2022-12

Conditions

Helicobacter Pylori Infection

Interventions

Furazolidone
Metronidazole

Primary outcomes

Eradication rates in 2 groups — 12 months
Both intention to treat(ITT) and per-protocol(PP) analyses will be used for the assessment of the eradication rates of Helicobacter pylori infections in two groups.

Countries

China